Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

First-in-human data for novel platelet glycoprotein IIb/IIIa inhibitor RUC-4 in patients with STEMI

Nov. 18, 2019

Gut bacteria can drive heart autoimmunity

Nov. 18, 2019

Bellerophon reports initial data from acute hemodynamic study of INOpulse

Nov. 13, 2019

Cerecor announces milestones in clinical development programs of CERC-301 and CERC-802

Nov. 12, 2019

Terns patents new MAP3K5 inhibitors

Nov. 5, 2019

Positive interim safety and efficacy data presented for OTS Allocetra

Nov. 5, 2019

Gene therapy can treat, prevent heart failure

Nov. 5, 2019

Cyclerion Therapeutics presents topline data from two phase II studies of praliciguat

Oct. 31, 2019

Hypothermia activates hypoxia protein, benefits metabolism

Oct. 30, 2019

MyoKardia announces promising results from phase IIa study of MYK-491

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...